Yet the stock still isn't dead. Think about that and let it sink in. Despite all the dilution, no real revenue, people still believe very strongly in what this little biotech has to offer. How much more so will it be worth when those days are behind us?
And if people are willing to put up with 500M of dilution over the last ~4 years, waiting a month or two to get to MAA will be nothing.
All this amounts to a reality in which your masters will be very unhappy.
News 
Market Data 
Discover 
